Investor Relations

Management

Image of Ehud Geller

Ehud Geller, PhD, MBA

CEO & Chairman

  • Former President & CEO of Interpharm Laboratories and EVP of Teva Group
  • Former head of the Israeli Pharmaceutical Manufacturers Association
  • Board member of the Tel Aviv Stock Exchange
  • National Industry award for contribution to biotech industry and management leadership
  • Samuel Johnson Medal Columbia University
  • Columbia University, Drexel Institute – Chemical Engineering (bio-chemical technology), MBA, PhD
Image of Galit Reske

Dr. Galit Reske, PhD

Chief Medical Officer

  • Over 15 years in clinical development, regulatory strategy and operations across the U.S., Europe and Israel
  • Former Director of Clinical Operations at CartiHeal; key role in FDA approval of Agili-C (2022) and the $330M acquisition by Smith+Nephew (2023)
  • Senior clinical roles at TechnoSTAT, Biovo Technologies and CRO Consultants
  • PhD in Molecular Biology, Hebrew University of Jerusalem
Image of Raz Simon

Raz Simon

VP Product & Applications

  • Over 17 years of integrated expertise across product development, clinical applications, operations, and commercialization in global healthcare markets
  • Proven leadership in startup and multinational corporations, specializing in cartilage repair, biomaterials, aesthetics, and spine—with a focus on user experience, risk management, and product improvement
  • BSc in Biotechnology Engineering, Braude College of Engineering, Karmiel
Image of Ori Gon

Ori Gon, CPA

CFO & CBO

  • Over 15 years of financial leadership experience across public and private enterprises and medical technology
  • CFO and financial leadership positions at Tactile Mobile, and Nasdaq listed Lifeward and On Track Innovations
  • Began his professional career as an auditor at KPMG Israel
  • CPA in Israel
  • Bachelor’s degree in Accounting and Finance from The Hebrew University of Jerusalem
Image of Nadyia

Nadya Lisovoder, MD

Director of Clinical Operations

  • Extensive international and domestic experience in clinical studies and CRO in the pharmaceutical, diagnostic and medical devices industry.
  • Comprehensive clinical studies capabilities from idea to final regulatory approval through the preclinical and clinical programs in USA, EU, Israel and Australia
  • Clinical and Clin-Ops management, medical writing, submissions.
  • M.D -Tel Aviv & Doneck Universities
Image of Liora Sklair – Tavron

Liora Sklair – Tavron, PhD

VP R&D

  • Over 20 years of R&D and Regulatory Affairs leadership across medtech and biopharma
  • 11 years leading project development at Teva
  • Senior Product Development and RA roles at Protalix (NASDAQ)
  • VP R&D and CEO roles at preclinical cancer therapy companies
  • PhD, Weizmann Institute; postdoc, Yale University authored peer-reviewed publications 
Image of Orly Amiran

Orly Amiran, M.Sc.

VP Quality & Regulatory Affairs

  • Over 20 years leading quality and regulatory management in pharma, biotech and medical devices
  • Senior roles at Teva, Sun Pharma and Pluri Biotech (Pluristem)
  • QMS and compliance (GMP, GDP, GCP, ISO 13485); FDA, EMA and Israeli MoH submissions and inspections
  • M.Sc. in Quality Assurance and Reliability, Technion; B.Sc. in Pharmacy, Hebrew University